The medication is indicated for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
Actionable ME/CFS study findings: While the DecodeME study was important for research into the immune system pathways, prior studies have also identified important genes related to ME/CFS susceptibility
The phone quality during my calls was poor, with a breaking connection and long hold times
A reference panel of 64,976 haplotypes for genotype imputation
Safety Considerations for Oral Wegovy According to FDA prescribing information, oral semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies
Please also gather any important health records or documentation from your primary care doctor that you feel may be helpful for us to review during your consultation.